[Federal Register Volume 60, Number 23 (Friday, February 3, 1995)]
[Notices]
[Pages 6719-6720]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2624]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration Advisory Council; 
Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), announcement is made of the 
following National Advisory body scheduled to meet during the month of 
March 1995.

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: March 1, 1995; 9:00 am-5:00 pm; March 2, 1995; 
9:00 am-12:00 noon. [[Page 6720]] 
    Place: Parklawn Building, Conference Rooms G & H, 5600 Fishers 
Lane, Rockville, Maryland 20857.
    The meeting is open to the public.
    Purpose: The Commission: (1) Advises the Secretary on the 
implementation of the Program, (2) on its own initiative or as the 
result of the filing of a petition, recommends changes in the 
Vaccine Injury Table, (3) advises the Secretary in implementing the 
Secretary's responsibilities under section 2127 regarding the need 
for childhood vaccination products that result in fewer or no 
significant adverse reactions, (4) surveys Federal, State, and local 
programs and activities relating to the gathering of information on 
injuries associated with the administration of childhood vaccines, 
including the adverse reaction reporting requirements of section 
2125(b), and advises the Secretary on means to obtain, compile, 
publish, and use credible data related to the frequency and severity 
of adverse reactions associated with childhood vaccines, and (5) 
recommends to the Director of the National Vaccine Program research 
related to vaccine injuries which should be conducted to carry out 
the National Vaccine Injury Compensation Program.
    Agenda: Agenda items will include, but not be limited to: a 
vaccine safety update from the Centers for Disease Control and 
Prevention and the Food and Drug Administration; a report on 
Children with Special Needs; a report on the National Vaccine 
Program; and routine Program reports.
    Public comment will be permitted before noon and at the end of 
the full Commission meeting on March 1; and before the Commission 
adjourns on the second day on March 2. Oral presentations will be 
limited to 5 minutes per public speaker.
    Persons interested in providing an oral presentation should 
submit a written request, along with a copy of their presentation to 
Mr. Jerry Anderson, Principal Staff Liaison, Division of Vaccine 
Injury Compensation, Bureau of Health Professions, Health Resources 
and Services Administration, Room 8A-35, 5600 Fishers Lane, 
Rockville, MD 20852; Telephone (301) 443-1533.
    Requests should contain the name, address, telephone number, and 
any business or professional affiliation of the person desiring to 
make an oral presentation. Groups having similar interests are 
requested to combine their comments and present them through a 
single representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. The Division of Vaccine 
Injury Compensation will notify each presenter by mail or telephone 
of their assigned presentation time. Persons who do not file an 
advance request for presentation, but desire to make an oral 
statement, may sign up in Conference Rooms G & H before 10:00 a.m. 
on March 1 and 2. These persons will be allocated time as time 
permits.
    Anyone requiring information regarding the Commission should 
contact Mr. Anderson, Division of Vaccine Injury Compensation, 
Bureau of Health Professions, Room 8A-35, 5600 Fishers Lane, 
Rockville, Maryland 20852; Telephone (301) 443-1533.
    Agenda Items are subject to change as priorities dictate.

    Dated: January 30, 1995.
Jackie E. Baum,
Advisory Committee Management Officer, HRSA.
[FR Doc. 95-2624 Filed 2-2-95; 8:45 am]
BILLING CODE 4160-15-P